Investing.com - CellaVision AB reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
CellaVision AB announced earnings per share of kr0.44 on revenue of kr141.00. Analysts polled by Investing.com anticipated EPS of kr1.31 on revenue of kr159.25M.
CellaVision AB shares are down 5.39% from the beginning of the year and are trading at kr241.00 , down-from-52-week-high.
CellaVision AB follows other major Healthcare sector earnings this month
CellaVision AB's report follows an earnings missed by Probi AB on October 21, who reported EPS of kr1.09 on revenue of kr145.1M, compared to forecasts EPS of kr2.65 on revenue of kr173M.
Hansa Biopharma had beat expectations on October 20 with third quarter EPS of kr-3.45 on revenue of kr67.08M, compared to forecast for EPS of kr-3.8 on revenue of kr26.69M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar